EUVIMEDEUVIMED entdecken
Crossref

Quinoline‐linked 1,2,3‐Triazole Hybrids: Design, Synthesis, Anticancer Activity and Computational Investigations

Rambabu Bhukya, Murali Krishna Vanga, Chandulal Bhukya, Vishnu Thumma iD, Ramchander Jadhav iD

Chemistry & Biodiversity · 14.04.2025

DOI: 10.1002/cbdv.202403184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 14.04.2025. Verfasst von Rambabu Bhukya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University College of Science, Osmania University, Hyderabad, India. Hauptthemen laut MEDLINE: Triazoles, Antineoplastic Agents, Quinolines, Drug Design. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synthesized a library of new quinoline‐based 1,2,3‐triazole scaffolds involving Suzuki‐Miyaura cross‐coupling and metal‐free multicomponent reactions. Evaluated their in vitro anticancer activities against human breast (MCF‐7), lung (A‐549) and liver (HepG2) cancer cell lines with reference to Doxorubicin as standard. Four compounds 5a , 5d , 5e and 5f displayed outstanding activity against all three cell lines. Compound 5a , showcasing ‐Cl in the R 2 position of the phenyl ring demonstrated potent activity with IC 50 values of 9.25 ± 0.22 , 9.56 ± 0.19 and 10.56 ± 0.19 µM against MCF‐7, A‐549 and HepG2 cell lines respectively. The compound 5f , containing m −Cl and m ‐OMe groups in R 1 and R 2 positions demonstrated potent activity with IC 50 values of 10.49 ± 0.31 (MCF‐7), 10.27 ± 0.27 (A‐549) and 11.27 ± 0.30 µM (HepG2). Compound 5f with −Cl and −I group presented potent activity with an IC 50 value of 11.40 ± 0.29 (MCF‐7), 10.42 ± 0.21 (A‐549) and 12.32 ± 0.33 µM (HepG2). Compound 5d gave out a potent activity with IC 50 values of 10.42 ± 0.25 (MCF‐7), 12.97 ± 0.22 (A‐549) and 13.05 ± 0.45 µM (HepG2). Toxicity results against Hek‐293 proved that these compounds were not harmful. The computational screening of these compounds revealed favourable drug‐likeness properties and important binding interactions against Fibroblast Growth Factor Receptor 1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazolesAntineoplastic AgentsQuinolinesDrug DesignHumansDrug Screening Assays, AntitumorStructure-Activity RelationshipCell ProliferationMolecular StructureDose-Response Relationship, DrugMolecular Docking SimulationCell Line, Tumor

Stichwörter der Autor:innen

1,2,3‐triazoleADME predictioncytotoxicitymolecular dockingquinoline

Substanzen

TriazolesAntineoplastic AgentsQuinolinesquinoline

Autor:innen und Institutionen

  • Department of Chemistry, University College of Science, Osmania University, Hyderabad, India.
  • Department of Sciences and Humanities, Matrusri Engineering College, Hyderabad, India.

ORCID-Profile: Vishnu Thumma, Ramchander Jadhav

Zitieren

APA

Bhukya, R., Vanga, M. K., Bhukya, C., Thumma, V., & Jadhav, R. (2025). Quinoline‐linked 1,2,3‐Triazole Hybrids: Design, Synthesis, Anticancer Activity and Computational Investigations. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202403184

Vancouver

Bhukya R, Vanga MK, Bhukya C, Thumma V, Jadhav R. Quinoline‐linked 1,2,3‐Triazole Hybrids: Design, Synthesis, Anticancer Activity and Computational Investigations. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202403184

BibTeX
@article{Bhukya2025,
  author = {Bhukya, Rambabu and Vanga, Murali Krishna and Bhukya, Chandulal and Thumma, Vishnu and Jadhav, Ramchander},
  title = {Quinoline‐linked 1,2,3‐Triazole Hybrids: Design, Synthesis, Anticancer Activity and Computational Investigations},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202403184}
}
Kostenlos starten →